A Prospective Randomised Controlled Trial of Iron Supplementation in Patients Scheduled for Colorectal Cancer Surgery
Completed
- Conditions
- Cancer: ColorectalCancerMalignant neoplasm of colon, malignant neoplasm of rectum
- Registration Number
- ISRCTN61221573
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
All patients seen in clinic with a diagnosis of colorectal cancer and fit for surgery will be eligible.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine whether giving iron supplements to patients at the time of diagnosis of colorectal cancer increases, or prevents the decrease, in their haemoglobin levels, and reduces allogeneic blood exposure.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of iron supplementation in colorectal cancer surgery outcomes?
How does iron supplementation compare to standard-of-care preoperative treatments for colorectal cancer patients?
Are there specific biomarkers that predict response to iron supplementation in malignant neoplasm of the colon and rectum?
What adverse events are associated with iron supplementation in colorectal cancer patients undergoing surgery?
What combination therapies or alternative compounds have been explored alongside iron supplementation for colorectal cancer treatment?